In contrast, the expression of Fhl1 is upregulated in cancers such as laryngeal carcinomas, gastric signet ring cell carcinoma, lung adenocarcinoma, gastric cancer, acute promyelocytic leukemia, and glioblastoma, among others. Here, FHL1 is linked to lung adenocarcinoma.